» Articles » PMID: 23849771

Genetic Factors and Multiple Sclerosis in the Moroccan Population: a Role for HLA Class II

Overview
Publisher Elsevier
Specialty Biology
Date 2013 Jul 16
PMID 23849771
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system that mainly affects young adults. The association between susceptibility to MS and HLA class II genes, in particular the DRB1*15 allele, has been reported in diverse ethnic groups. The aim of our study was to investigate the distribution of HLA-DRB1* and -DQB1* alleles in Moroccan population and their implication in the susceptibility to the disease.

Methods: Fifty-seven MS patients were compared to 172 healthy controls unrelated to one another and matched by age, sex and ethnic origin. HLA class II (DRB1* and DQB1*) typing was performed by PCR-SSP and/or Luminex (PCR-SSO). Allelic and haplotypic frequencies, P-values, odds ratio (OR) and 95% confidence interval (CI) were calculated using the software SPSS.

Results: A significant increase of DRB1*15 allele frequency (17.6% vs 8.4%, OR=2.67, 95% CI=1.36-5.23, P=0.004) and HLA-DRB1*15-DQB1*06 haplotype (8.8% vs 4.08%, OR=2.78, 95% CI=1.41-5.48, P=0.002) were observed in Moroccan MS patients. No association of the DR15 allele with sex or age at onset was appreciated. Concerning HLA-DQB1* alleles, no significant difference between patients and controls was found.

Conclusions: Our results reveal a role for HLA-DRB1*15 allele molecules in the predisposition of Moroccan patients to MS. Although this study should be confirmed on a larger sample size, it analyzes for the first time the possible role of a genetic marker for susceptibility to MS in Moroccan population.

Citing Articles

Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco.

Fguirouche A, Ouahmani F, Brahim I, Hazime R, Louhab N, Kissani N Clin Pract. 2025; 15(1).

PMID: 39851793 PMC: 11763420. DOI: 10.3390/clinpract15010010.


Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.

Olfati H, Ghoshouni H, Ebrahimi N, Mohammadi A, Ghajarzadeh M Mult Scler Int. 2022; 2022:7091140.

PMID: 36536783 PMC: 9759394. DOI: 10.1155/2022/7091140.


How Does the Immune System Enter the Brain?.

Mapunda J, Tibar H, Regragui W, Engelhardt B Front Immunol. 2022; 13:805657.

PMID: 35273596 PMC: 8902072. DOI: 10.3389/fimmu.2022.805657.


Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region.

Maghbooli Z, Sahraian M, Naser Moghadasi A Mult Scler J Exp Transl Clin. 2020; 6(1):2055217319881775.

PMID: 31976083 PMC: 6956601. DOI: 10.1177/2055217319881775.


Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses.

Gontika M, Anagnostouli M Mult Scler Int. 2019; 2018:8487471.

PMID: 30595920 PMC: 6282147. DOI: 10.1155/2018/8487471.